RxDoctor Payments Data

Samrat Patel, MD

Hospitalist · Bowling Green, KYNPI 1043574155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 42.7% of the total. Reporting peaked in 2021 at $589 and has fallen 87.4% since, to $74 in 2025. Among hospitalist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,597in general payments, 2019–2025

Across 85 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$682
  • AbbVie$197
  • Novartis$174
  • AstraZeneca$167
  • Merck$118
  • E.r. Squibb & Sons, L.L.C.$93
  • plus $166 from 8 others

What the payments were for

  • Food & beverage$1,597100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,597 in reported general payments places this provider in the 95th percentile of 258 hospitalist providers in Kentucky.

See all hospitalist providers in Kentucky

Medicare billing

Part B allowed, 2024
$87,768
Medicare patients
304
Services billed
914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$41

Paid to pharmacies, not to this prescriber.

Other hospitalist in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →